CHILDREN EXPOSED TO METHAMPHETAMINE USE AND MANUFACTURE

接触甲基苯丙胺使用和制造的儿童

• 批准号: 6902725
• 负责人: NENA Portia MESSINA
• 金额: $ 18.51万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-08-01 至 2007-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6902725
• 关键词: behavioral /social science research tag; child abuse; child foster care /adoption; child psychology; child welfare; children; clinical research; developmental disease /disorder; drug addiction; family structure /dynamics; human data; human population study; legal /correctional; methamphetamine; social problems; statistics /biometry; substance abuse epidemiology

DESCRIPTION (provided by applicant): The two-year pilot study, to be conducted by UCLA Integrated Substance Abuse Programs (ISAP), is designed to explore the epidemiology and the medical, developmental, and placement outcomes of children removed from home-based methamphetamine laboratories (MA labs). Specifically, UCLA ISAP will analyze multidisciplinary data on drug-endangered children to enhance scientific understanding of the epidemiology and the medical (e.g., respiratory, dental, dermatological) and developmental (e.g., delays, psychosocial) problems of MA-exposed children, as well as the child-welfare case management services, treatment, and placement outcomes for these children. This study will include the cooperation of the Los Angeles Drug Endangered Children (DEC) program and the Los Angeles Department of Children and Family Services. The DEC multidisciplinary programs are composed of narcotic officers, child protective services personnel, medical professionals, and prosecutors working together to protect children endangered by parental drug production, use, and sales. The specific aims of this study are: 1) To analyze multidisciplinary data on drug-endangered children to describe the problems (e.g., medical and developmental assessments) and the placement outcomes (i.e., child protective services 18-month case dispositions) of children removed from home-based MA labs; 2) To analyze the placement outcomes of children removed from home-based MA labs in the context of legal timelines of the Adoption and Safe Families Act (ASFA) and California legislation requirements for filing felony child endangerment charges; and 3) To create opportunities for multidisciplinary collaboration among researchers, law enforcement, child protective services, medical providers, and prosecutors to sustain the proposed study efforts, and to help guide child welfare policy on substance abusing families in California and other states that have drug-endangered programs through Advisory Board meetings and dissemination of results.

描述（由申请人提供）：将由UCLA综合药物滥用计划（ISAP）进行的为期两年的试点研究旨在探索从基于家庭的甲基苯丙胺实验室（MA Labs）中删除的儿童的流行病学以及医疗，发育和安置结果。具体而言，UCLA ISAP将分析有关药物偏见的儿童的多学科数据，以增强对流行病学和医学（例如呼吸道，牙科，皮肤病学）和发育（例如延迟，心理社会，公认的儿童的心理社会问题）的科学理解，以及儿童案例管理案件管理服务，以及儿童的待遇，以及这些儿童的副本，以这些儿童和这些儿童的位置来处理这些问题。这项研究将包括洛杉矶药物濒危儿童（DEC）计划和洛杉矶儿童和家庭服务部的合作。 DEC多学科计划由麻醉官员，儿童保护服务人员，医疗专业人员和检察官共同努力，以保护因父母的药物生产，使用和销售而危害的儿童。这项研究的具体目的是：1）分析有关药物抑制儿童的多学科数据，以描述从家庭MA Labs撤离的儿童的问题（例如，医疗和发育评估）以及撤离家庭MA Labs的儿童的放置结果（即儿童保护服务18个月的病例处置）； 2）分析《收养与安全家庭法》（ASFA）的法律时间表（ASFA）和加利福尼亚州立法要求提出重罪儿童危害指控的要求； 3）为研究人员，执法部门，儿童保护服务，医疗提供者和检察官之间的多学科合作创造机会，以维持拟议的研究工作，并帮助指导儿童福利政策，以滥用加利福尼亚州的家庭和其他通过咨询董事会会议和成果的毒品倾向的计划，这些州与毒品倾向的计划。